Abstract:OBJECTIVE:To construct recombinant plasmid with human atrial natriuretic peptide (ANP) gene in fusion form for stable and high level expression of genetic engineering product ANP in E. coli system.METHODS:Plasmids with ANP fusion gene were constructed by PCR and sub-cloning and fusion protein was expressed in E. coli system. High level expression of the fusion genes was enhanced by linking operons in tandem. ANP was released from the fusion protein with thrombin treatment and purified by chromatography. Genetic-engineered ANP was evaluated with the drug production requirement, and produced ANP was tested for its effects of lowering blood pressure and diuresis in vivo and vasodilation in vitro.RESULTS:A series of 4 plasmid pCW111-114, containing 1 to 4 gene operons respectively, were constructed, and the yields of fusion protein were 46%, 54.8%, 56.1% and 60.1% of total cell protein. Fusion protein in the form of inclusion body was isolated and purified, and then treated with thrombin to release ANP. After purification using chromatography columns, at least 3 mg/L culture of ANP with the purity higher than 96% was produced in shaking flask. Primary pharmacological evaluation showed the produced ANP had the effects of blood pressure lowering in vivo and diuresis in vivo and vasodilation in vitro, which was similar to the activity of standard ANP.CONCLUSIONS:By the protocol of fusion gene cloning and expression, the human ANP was produced successfully in E. coli system.

Construction and Expression of Human Angiogenin-PE40Fusion Protein

Expression and Purification of Angiogenin-Egfp Fusion Protein in E.coli

Cloning and Expression of Human Angiogenin Gene

Construction of Recombinant Vector Pegfp-Ang and Expression of Angiogenin Gene in HUVECs

[Human Angiogenin: Expression, Purification, Biological Assay].

[High Level Expression of Human Atrial Natriuretic Peptide in Fusion Form in E. Coli System].

Construction and Expression of a Recombinant Immunotoxin Against Human Glioma, SZ39(ScFv)-PE40

Construction and identification of human Angiopoietin2 prokaryotic expression vector

Cloning and Expression of Human Angiogenin Cdna in E.coli

Construction of fusion gene vector of α-BGT and its expression in E.coli BL21(DE3)

Construction and Expression of Recombinant Human B-type Natriuretic Peptide (Hbnp-32)

Construction of Expression Vector for Recombinant DT/bFGF Fusion Protein and Purification of Expressed Product

Construction and Expression of Anti-Glioma Single-Chain Fv/human Tumor Necrosis Factor Α Fusion Gene

The Construction of Anti-EGFR Single Chain Variable Fragment Fused with Gelonin Toxin Prokaryotic Expressing Plasmid and the Study of Its Anti-tumor Effects

CONSTRUCTION OF RECOMBINANT PLASMID EXPRESSING A NOVEL PROTEIN hEPO/TNFαM

Construction of recombinant adenovirus vector co-expressing angiopoietin-1 and report gene EGFP

Construction of a Eukaryotic Expression Vector Hvegf_(165)-Fused Hirudin/pcdna3.0 and Its Expression

Induced Expression and Optimal Expression Conditions of Recombinant Alpha-bungarotoxin Gene Fusion Protein

Construction of recombinant expression vector of granulysin gene and its prokaryotic expression

Construction and expression of enhanced green fluorescent protein and HGF co-expression vector

Construction and Expression of Stx1A-LHRH Fusion Toxin.